bioRxiv Science⌕ Search

Biology subjects

Blanch-Asensio, M.

Publications and source records attributed to Blanch-Asensio, M..

3 recordsLinked to original sources

Genetic and materials engineering to enhance inducible gene expression in lactobacilli

Lactiplantibacillus plantarum is known for its potential in healthcare, food production, and environmental biotechnology. However, its broader utility is constrained by a limited genetic toolbox, particularly lacking robust genetic switches for inducible gene expression. Addressing this gap, we developed a novel genetic switch for L. plantarum based on a strong bacteriophage-derived promoter and the food-grade inducer, cumate. However, the switch was susceptible to leaky expression in the late log phase of bacterial growth, which was correlated to a reduction in the culture pH. This leakiness was partially resolved by regulating culture conditions (temperature and nutrients) to limit growth below a certain bacterial density. More interestingly, leaky expression could be stably suppressed by encapsulating the bacteria in alginate as an engineered living material. This physically restricted growth and limited the pHdrop, thereby enhancing the switch performance. The possibilities to regulate protein secretion over several days, reversibly switch protein production, and establish dual functionalities by co-encapsulating strains with different switches were demonstrated. Thus, for the first time, we show a material-based strategy to enhance the performance of a genetic switch in bacteria. This strategy facilitates the development of L. plantarum for advanced applications in biotechnology, pharmaceutics, and living therapeutics.

bioengineering↗

PEARL: Protein Eluting Alginate with Recombinant Lactobacilli

Engineered living materials (ELMs) made of bacteria in hydrogels have shown considerable promise for therapeutic applications through controlled and sustained release of complex biopharmaceuticals at low costs and with reduced wastage. While most therapeutic ELMs use E. coli due to its large genetic toolbox, most live biotherapeutic bacteria in development are lactic acid bacteria due to native health benefits they offer. Among these, lactobacilli form the largest family of probiotics with therapeutic potential in almost all sites of the body with a microbiome. A major factor limiting the use of lactobacilli in ELMs is their limited genetic toolbox. In this study, we build upon our recent work to expand the genetic programmability of probiotic Lactiplantibacillus plantarum WCFS1 for protein secretion and encapsulate it in a simple, cost-effective, and biocompatible core-shell alginate bead to develop an ELM. We demonstrate the controlled release of recombinant proteins, even up to 14 days from this ELM, thereby terming it PEARL - Protein Eluting Alginate with Recombinant Lactobacilli. Notably, lactobacillus encapsulation offered benefits like bacterial containment, protein release profile stabilization, and metabolite-induced cytotoxicity prevention. These findings demonstrate the mutual benefits of combining recombinant lactobacilli with alginate for the controlled and sustained release of proteins.

bioengineering↗

Discovery of a high-performance phage-derived promoter/repressor system for probiotic lactobacillus engineering

BackgroundThe Lactobacillus family comprises many species of great importance for the food and healthcare industries, with numerous strains identified as beneficial for humans and used as probiotics. Hence, there is a growing interest in engineering these probiotic bacteria as live biotherapeutics for animals and humans. However, the genetic parts needed to regulate gene expression in these bacteria remain limited compared to model bacteria like E. coli or B. subtilis. To address this deficit, in this study, we selected and tested several bacteriophage-derived genetic parts with the potential to regulate transcription in lactobacilli. ResultsWe screened genetic parts from 6 different lactobacilli-infecting phages and identified one promoter/repressor system with unprecedented functionality in L. plantarum WCFS1. The phage-derived promoter was found to achieve expression levels nearly 9-fold higher than the previously reported strongest promoter in this strain and the repressor was able to almost completely repress this expression by reducing it nearly 500-fold. ConclusionsThe new parts and insights gained from their engineering will enhance the genetic programmability of lactobacilli for healthcare and industrial applications.

synthetic biology↗